Order Article Reprints

Sivridaş M, Creemers RH, Wong DR, Boekema PJ, Römkens TEH, Gilissen LPL, van Bodegraven AA, Loeff FC, Rispens T, Derijks LJJ. Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study. Pharmaceutics. 2023; 15(3):972. https://doi.org/10.3390/pharmaceutics15030972

Sivridaş, Merve, Rob H. Creemers, Dennis R. Wong, Paul J. Boekema, Tessa E. H. Römkens, Lennard P. L. Gilissen, Adriaan A. van Bodegraven, Floris C. Loeff, Theo Rispens, and Luc J. J. Derijks. 2023. "Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study" Pharmaceutics 15, no. 3: 972. https://doi.org/10.3390/pharmaceutics15030972

Sivridaş, M., Creemers, R. H., Wong, D. R., Boekema, P. J., Römkens, T. E. H., Gilissen, L. P. L., van Bodegraven, A. A., Loeff, F. C., Rispens, T., & Derijks, L. J. J. (2023). Therapeutic Drug Monitoring of Vedolizumab in Inflammatory Bowel Disease Patients during Maintenance Treatment—TUMMY Study. Pharmaceutics, 15(3), 972. https://doi.org/10.3390/pharmaceutics15030972